
FDA Draft Guidance on Q-Submission Program: Overview
The article provides a general overview of the revised guidance document and highlights the key points related to the existing legal framework.
The article provides a general overview of the revised guidance document and highlights the key points related to the existing legal framework.
The new article pays attention to the general questions associated with Q-Submissions that medical device manufacturers may use to request additional feedback from the authority before submitting an actual application for marketing approval.
The new article describes in detail the aspects of the different types of interactions with the authority within the Q-Submission concept, emphasizing their specific features and use cases
The new article highlights the aspects related to the applicability scope, and also provides definitions of the key terms and concepts.
The article highlights the key points associated with factors to be considered when determining the eligibility of a medical device type for a third-party review program under the 510(k) framework.
The article highlights the aspects related to the key considerations for methodologies used in the context of the collection and analysis of real-world evidence.